Extinction is still forever, but scientists are trying what they say is the next best thing to restoring ancient beasts — engineering animals with qualities to resemble extinct species.
Recent research from Duke University has demonstrated a promising new approach that could be used to treat a rare and complex ...
Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP) - a ...
Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...
When Vijay Sankaran was an MD-PhD student at Harvard Medical School in the mid-2000s, one of his first clinical encounters ...
Antibiotic resistance is a global concern that threatens our ability to prevent and treat bacterial infections in humans and ...
Intellia Therapeutics’ stock faces risks from market uncertainty and funding needs. Read why NTLA stock is downgraded to HOLD ...
A recent study by the University of Cologne has illuminated a specific tau protein's role in the progression of Alzheimer's ...
Intellia Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Intellia's technology platform specializes in Clustered Regularly Interspaced Short ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback